← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VIWIT PHARM · Approved 2026-03-19

Drug application

FDA Application #
ANDA220071
Application type
Abbreviated New Drug Application (Generic)
Brand name
LIDOCAINE HYDROCHLORIDE
Generic name
Lidocaine Hydrochloride
Active ingredients
LIDOCAINE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
VIWIT PHARM
First approval
2026-03-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown